a Imprinting and Cancer group, Cancer Epigenetics and Biology Program (PEBC) , Institut d'Investigació Biomedica de Bellvitge (IDIBELL) , Avinguda Granvia, L'Hospitalet de Llobregat , Barcelona , Spain.
b Cancer Epigenetics group, Cancer Epigenetics and Biology Program (PEBC) , Institut d'Investigació Biomedica de Bellvitge (IDIBELL) , Avinguda Granvia, L'Hospitalet de Llobregat , Barcelona , Spain.
Epigenetics. 2018;13(2):182-191. doi: 10.1080/15592294.2017.1344803. Epub 2018 Mar 5.
DNA methylation (5-methylcytosine, 5 mC) is involved in many cellular processes and is an epigenetic mechanism primarily associated with transcriptional repression. The recent discovery that 5 mC can be oxidized to 5-hydromethylcytosine (5hmC) by TET proteins has revealed the "sixth base" of DNA and provides additional complexity to what was originally thought to be a stable repressive mark. However, our knowledge of the genome-wide distribution of 5hmC in different tissues is currently limited. Here, we sought to define loci enriched for 5hmC in the placenta genome by combining oxidative bisulphite (oxBS) treatment with high-density Illumina Infinium HumanMethylation450 methylation arrays and to compare our results with those obtained in brain. Despite identifying over 17,000 high-confidence CpG sites with consistent 5hmC enrichment, the distribution of this modification in placenta is relatively sparse when compared to cerebellum and frontal cortex. Supported by validation using allelic T4 β-glucosyltransferase assays we identify 5hmC at numerous imprinted loci, often overlapping regions associated with parent-of-origin allelic 5 mC in both placenta and brain samples. Furthermore, we observe tissue-specific monoallelic enrichment of 5hmC overlapping large clusters of imprinted snoRNAs-miRNAs processed from long noncoding RNAs (lncRNAs) within the DLK1-DIO3 cluster on chromosome 14 and SNRPN-UBE3A domain on chromosome 15. Enrichment is observed solely on the transcribed alleles suggesting 5hmC is positively associated with transcription at these loci. Our study provides an extensive description of the 5hmC/5 mC landscape in placenta with our data available at www.humanimprints.net , which represents the most comprehensive resource for exploring the epigenetic profiles associated with human imprinted genes.
DNA 甲基化(5-甲基胞嘧啶,5mC)参与许多细胞过程,是一种主要与转录抑制相关的表观遗传机制。最近发现 TET 蛋白可以将 5mC 氧化为 5-羟甲基胞嘧啶(5hmC),这揭示了 DNA 的“第六碱基”,为最初被认为是稳定抑制标记的内容增添了更多复杂性。然而,我们目前对不同组织中 5hmC 的全基因组分布的了解还很有限。在这里,我们试图通过结合氧化亚硫酸氢盐(oxBS)处理和高密度 Illumina Infinium HumanMethylation450 甲基化阵列,来确定胎盘基因组中富含 5hmC 的基因座,并将我们的结果与大脑中的结果进行比较。尽管确定了 17000 多个具有一致 5hmC 富集的高可信度 CpG 位点,但与小脑和额叶皮层相比,这种修饰在胎盘中的分布相对稀疏。通过使用等位基因 T4 β-葡萄糖基转移酶测定进行验证,我们在许多印迹基因座中鉴定到 5hmC,这些基因座通常与胎盘和脑组织样本中与亲本等位基因 5mC 重叠的区域相关。此外,我们观察到组织特异性单等位基因富集的 5hmC 与印迹 snoRNAs-miRNAs 重叠,这些 snoRNAs-miRNAs 来自长非编码 RNA(lncRNA)在 14 号染色体上的 DLK1-DIO3 簇和 15 号染色体上的 SNRPN-UBE3A 结构域。富集仅发生在转录等位基因上,这表明 5hmC 与这些基因座的转录呈正相关。我们的研究提供了胎盘 5hmC/5mC 景观的广泛描述,我们的数据可在 www.humanimprints.net 上获得,这是探索与人类印迹基因相关的表观遗传特征的最全面资源。